Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 83(2024), 4 vom: 12. März, Seite 541-543 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Trefond, Ludovic [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
73B0K5S26A |
|---|
| Anmerkungen: |
Date Completed 14.03.2024 Date Revised 14.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/ard-2023-225023 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366145991 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366145991 | ||
| 003 | DE-627 | ||
| 005 | 20240314234754.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/ard-2023-225023 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1328.xml |
| 035 | |a (DE-627)NLM366145991 | ||
| 035 | |a (NLM)38123937 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Trefond, Ludovic |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.03.2024 | ||
| 500 | |a Date Revised 14.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Biological Therapy | |
| 650 | 4 | |a Connective Tissue Diseases | |
| 650 | 4 | |a Lupus Erythematosus, Systemic | |
| 650 | 7 | |a belimumab |2 NLM | |
| 650 | 7 | |a 73B0K5S26A |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 700 | 1 | |a Zahr, Noël |e verfasserin |4 aut | |
| 700 | 1 | |a Lhote, Raphael |e verfasserin |4 aut | |
| 700 | 1 | |a Pha, Micheline |e verfasserin |4 aut | |
| 700 | 1 | |a Hié, Miguel |e verfasserin |4 aut | |
| 700 | 1 | |a Miyara, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Papo, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Moyon, Quentin |e verfasserin |4 aut | |
| 700 | 1 | |a Hausfater, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Chasset, Francois |e verfasserin |4 aut | |
| 700 | 1 | |a Haroche, Julien |e verfasserin |4 aut | |
| 700 | 1 | |a Cohen-Aubart, Fleur |e verfasserin |4 aut | |
| 700 | 1 | |a Mathian, Alexis |e verfasserin |4 aut | |
| 700 | 1 | |a Amoura, Zahir |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 83(2024), 4 vom: 12. März, Seite 541-543 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2024 |g number:4 |g day:12 |g month:03 |g pages:541-543 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/ard-2023-225023 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2024 |e 4 |b 12 |c 03 |h 541-543 | ||